XML 56 R44.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stock-Based Compensation - Stock option activity (Details) - USD ($)
3 Months Ended 6 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2024
Mar. 31, 2023
Weighted Average Remaining Contractual Term (Years)        
Stock-based compensation expense $ 1,310,507 $ 1,383,405 $ 2,583,118 $ 2,775,798
Employee Stock Option [Member]        
Number of Shares        
Balance, Beginning (in shares)     1,197,774  
Granted (in shares)     799,729  
Forfeited (in shares)     29,605  
Expired (in shares)     8,333  
Balance, Ending (in shares) 1,959,565   1,959,565  
Exercisable (in shares) 875,865   875,865  
Vested and expected to vest (in shares) 1,959,565   1,959,565  
Weighted Average Exercise Price        
Balance, Beginning (in dollars per share)     $ 28.72  
Granted (in dollars per share)     6.70  
Forfeited (in dollars per share)     27.93  
Expired (in dollars per share)     33.60  
Balance, Ending (in dollars per share) $ 19.72   19.72  
Exercisable (in dollars per share) 27.62   27.62  
Vested and expected to vest (in dollars per share) $ 19.72   $ 19.72  
Weighted Average Remaining Contractual Term (Years)        
Balance-Remaining contractual term     8 years 2 months 12 days  
Vested and exercisable -Remaining contractual term     7 years  
Vested and expected to vest-Remaining contractual term     8 years 2 months 12 days  
Aggregate intrinsic value, Outstanding $ 4,219,550   $ 4,219,550  
Aggregate intrinsic value, Vested and exercisable 383,313   383,313  
Aggregate intrinsic value, Vested and expected to vest $ 4,219,550   $ 4,219,550  
Grant date fair value of options (in dollars per share)     $ 6.06 $ 19.20
Performance-based stock options        
Number of Shares        
Balance, Beginning (in shares)     35,000  
Granted (in shares)     634,000  
Balance, Ending (in shares) 669,000   669,000  
Vested and exercisable (in shares) 35,000   35,000  
Vested and expected to vest (in shares) 669,000   669,000  
Weighted Average Exercise Price        
Balance, Beginning (in dollars per share)     $ 28.80  
Granted (in dollars per share)     6.78  
Balance, Ending (in dollars per share) $ 7.93   7.93  
Vested and exercisable (in dollars per share) 28.80   28.80  
Vested and expected to vest (in dollars per share) $ 7.93   $ 7.93  
Weighted Average Remaining Contractual Term (Years)        
Balance-Remaining contractual term     9 years 10 months 24 days  
Vested and exercisable -Remaining contractual term     7 years 8 months 12 days  
Vested and expected to vest-Remaining contractual term     9 years 10 months 24 days  
Aggregate intrinsic value, Outstanding $ 3,271,440   $ 3,271,440  
Aggregate intrinsic value, Vested and expected to vest $ 3,271,440   $ 3,271,440  
Term of award     10 years  
Grant date fair value of options (in dollars per share)       $ 6.52